About NanoMedSyn





NanoMedSyn was born from the fundamental research of its biologist and chemist founders who discovered a breakthrough technology for drug delivery to the lysosomal cell compartment leading to potentiation of therapeutics. This technology, validated at the preclinical level, has a wide range of applications in the fields of oncology, immunity, inflammation or metabolism.

Professional experts

Our researchers have years of experience in the field of nanotechnologies.

Innovative technology

The AMFA is a patented synthetic derivative designed for the targeting of the mannose 6-phosphate receptor.

New talents

NanoMedSyn is growing up and has already recruted new doctors to cope with its needs.